Trial Profile
A Phase IIb Study to Investigate the Treatment-Sparing Effects of AEROVANT AER 001 Inhalation Powder in Asthma Patients Not Fully Controlled on Current Therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitrakinra (Primary)
- Indications Asthma
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms AEROTRIAL
- Sponsors Aerovance
- 01 Sep 2011 Planned number of patients changed from 500 to 536.
- 25 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2010 Results have been presented at the 20th Annual Congress of the European Respiratory Society.